Jeffrey B. Shiroky

875 total citations
16 papers, 669 citations indexed

About

Jeffrey B. Shiroky is a scholar working on Rheumatology, Genetics and Oncology. According to data from OpenAlex, Jeffrey B. Shiroky has authored 16 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Jeffrey B. Shiroky's work include Rheumatoid Arthritis Research and Therapies (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Jeffrey B. Shiroky is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Jeffrey B. Shiroky collaborates with scholars based in Canada, United States and United Kingdom. Jeffrey B. Shiroky's co-authors include Carolyn Neville, Marianna M. Newkirk, Marc Cohen, John M. Esdaile, Jane Skelton, A. Frost, David G. Haegert, Carey Levinton, John Sibley and M Haga and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Jeffrey B. Shiroky

15 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey B. Shiroky Canada 12 397 142 111 92 90 16 669
S Kaufman Israel 11 153 0.4× 185 1.3× 200 1.8× 63 0.7× 66 0.7× 30 688
Kristina Albertsson Sweden 12 756 1.9× 237 1.7× 143 1.3× 129 1.4× 114 1.3× 12 984
Béatrice Pallot-Pradès France 12 334 0.8× 75 0.5× 163 1.5× 52 0.6× 74 0.8× 24 594
Maher Issa United States 19 493 1.2× 182 1.3× 120 1.1× 151 1.6× 130 1.4× 26 965
Merete Pedersen Denmark 8 483 1.2× 83 0.6× 107 1.0× 92 1.0× 57 0.6× 14 720
E. Lubberts Netherlands 3 745 1.9× 316 2.2× 127 1.1× 128 1.4× 70 0.8× 4 879
Maria Gabriella Raimondo Germany 13 413 1.0× 154 1.1× 196 1.8× 61 0.7× 68 0.8× 33 745
Greet Esselens Belgium 6 287 0.7× 80 0.6× 50 0.5× 60 0.7× 44 0.5× 7 428
G S Alarcón United States 12 394 1.0× 122 0.9× 93 0.8× 93 1.0× 50 0.6× 23 585
Darcy S. Majka United States 10 463 1.2× 94 0.7× 126 1.1× 49 0.5× 37 0.4× 15 647

Countries citing papers authored by Jeffrey B. Shiroky

Since Specialization
Citations

This map shows the geographic impact of Jeffrey B. Shiroky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey B. Shiroky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey B. Shiroky more than expected).

Fields of papers citing papers by Jeffrey B. Shiroky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey B. Shiroky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey B. Shiroky. The network helps show where Jeffrey B. Shiroky may publish in the future.

Co-authorship network of co-authors of Jeffrey B. Shiroky

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey B. Shiroky. A scholar is included among the top collaborators of Jeffrey B. Shiroky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey B. Shiroky. Jeffrey B. Shiroky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Shiroky, Jeffrey B., et al.. (1997). THE USE OF FOLATES CONCOMITANTLY WITH LOW-DOSE PULSE METHOTREXATE. Rheumatic Disease Clinics of North America. 23(4). 969–980. 22 indexed citations
2.
Clarke, Ann E., Hanna Zowall, Carey Levinton, et al.. (1997). Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.. PubMed. 24(6). 1051–60. 118 indexed citations
3.
Shiroky, Jeffrey B.. (1996). Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.. PubMed. 44. 69–71.
4.
Newkirk, Marianna M., Jeffrey B. Shiroky, Newell W. Johnson, et al.. (1995). RHEUMATIC DISEASE PATIENTS, PRONE TO SJÖGREN'S SYNDROME AND/OR LYMPHOMA, MOUNT AN ANTIBODY RESPONSE TO BHRF1, THE EPSTEIN-BARR VIRAL HOMOLOGUE OF BCL-2. Lara D. Veeken. 35(11). 1075–1081. 22 indexed citations
5.
6.
Shiroky, Jeffrey B.. (1994). Reply. Arthritis & Rheumatism. 37(3). 444–445. 1 indexed citations
7.
8.
Shiroky, Jeffrey B., Carolyn Neville, John M. Esdaile, et al.. (1993). Low‐dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. results of a multicenter randomized, double‐blind, placebo‐controlled trial. Arthritis & Rheumatism. 36(6). 795–803. 101 indexed citations
9.
Shiroky, Jeffrey B., et al.. (1993). Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey.. Annals of the Rheumatic Diseases. 52(6). 454–456. 93 indexed citations
10.
Shiroky, Jeffrey B., Carolyn Neville, & Jane Skelton. (1992). High dose intravenous methotrexate for refractory rheumatoid arthritis.. PubMed. 19(2). 247–51. 13 indexed citations
11.
Shiroky, Jeffrey B., A. Frost, Jane Skelton, et al.. (1991). Complications of immunosuppression associated with weekly low dose methotrexate.. PubMed. 18(8). 1172–5. 86 indexed citations
12.
Shiroky, Jeffrey B., et al.. (1989). Combination methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observations. Arthritis & Rheumatism. 32(9). 1160–1164. 17 indexed citations
13.
Atkinson, Jane C., et al.. (1989). Effects of Furosemide on the Oral Cavity. Gerodontology. 8(1). 23–26. 27 indexed citations
14.
Williams, H. James, John Ward, Stephen L. Dahl, et al.. (1988). A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis & Rheumatism. 31(6). 702–713. 89 indexed citations
15.
Shiroky, Jeffrey B., et al.. (1988). High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis.. PubMed. 15(2). 251–5. 9 indexed citations
16.
Kaufman, Marc J., et al.. (1978). Some Properties of the Specific Androgen-Binding Activities in Cultured Human Genital Skin Fibroblasts*. The Journal of Clinical Endocrinology & Metabolism. 47(4). 738–745. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Kaufman Breakdown of academic impact, for papers by Kristina Albertsson Breakdown of academic impact, for papers by Béatrice Pallot-Pradès Breakdown of academic impact, for papers by Maher Issa Breakdown of academic impact, for papers by Merete Pedersen Breakdown of academic impact, for papers by E. Lubberts Breakdown of academic impact, for papers by Maria Gabriella Raimondo Breakdown of academic impact, for papers by Greet Esselens Breakdown of academic impact, for papers by G S Alarcón Breakdown of academic impact, for papers by Darcy S. Majka
Rankless by CCL
2026